| scholarly article | Q13442814 |
| P50 | author | Kristina Grabusic | Q58128851 |
| P2093 | author name string | Sabine Maier | |
| Elisabeth Kremmer | |||
| Anja Mantik | |||
| Bettina Kempkes | |||
| Maja Santak | |||
| Wolfgang Hammerschmidt | |||
| P2860 | cites work | DNA ligase IV is essential for V(D)J recombination and DNA double-strand break repair in human precursor lymphocytes | Q22007974 |
| CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex | Q22008610 | ||
| SKIP, a CBF1-associated protein, interacts with the ankyrin repeat domain of NotchIC To facilitate NotchIC function | Q22253329 | ||
| Human Jk recombination signal binding protein gene (IGKJRB): comparison with its mouse homologue | Q24318408 | ||
| A role for SKIP in EBNA2 activation of CBF1-repressed promoters | Q24524363 | ||
| A histone deacetylase corepressor complex regulates the Notch signal transduction pathway | Q24598533 | ||
| EBNA2 and Activated Notch Induce Expression of BATF | Q24679432 | ||
| Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathway | Q24682515 | ||
| Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2 | Q28284326 | ||
| Two species of human Fc epsilon receptor II (Fc epsilon RII/CD23): tissue-specific and IL-4-specific regulation of gene expression | Q28285961 | ||
| RBP-L, a transcription factor related to RBP-Jkappa | Q28508784 | ||
| A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation | Q40811596 | ||
| Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells. | Q41063703 | ||
| Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines | Q41234160 | ||
| Epstein-Barr virus (EBV) nuclear-antigen-2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context | Q41579150 | ||
| Modulation of cellular gene expression in B lymphoma cells followingin vitro infection by Epstein-Barr virus (EBV) | Q41718399 | ||
| Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2. | Q44697821 | ||
| Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B). | Q45733831 | ||
| Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa | Q45781476 | ||
| An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene. | Q48038461 | ||
| Optimization of the hygromycin B resistance-conferring gene as a dominant selectable marker in mammalian cells | Q58053916 | ||
| Conservation of the Notch signalling pathway in mammalian neurogenesis | Q28513429 | ||
| Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells | Q28594415 | ||
| Regulation of notch signaling activity | Q28610136 | ||
| Disruption of the mouse RBP-J kappa gene results in early embryonic death | Q28610816 | ||
| Gene targeting and somatic cell genetics--a rebirth or a coming of age? | Q33594280 | ||
| Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2. | Q33797347 | ||
| Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus | Q33842309 | ||
| Activated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells | Q33850400 | ||
| Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection | Q33851043 | ||
| Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex | Q33932719 | ||
| Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosis | Q34154616 | ||
| Reduction of Background Problems in Nonradioactive Northern and Southern Blot Analyses Enables Higher Sensitivity Than 32P-Based Hybridizations | Q34306277 | ||
| The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. | Q34327455 | ||
| Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. | Q34625121 | ||
| Regulation of B cell development by Notch/RBP-J signaling | Q35101899 | ||
| The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein | Q35648541 | ||
| Viral interactions with the Notch pathway | Q35853119 | ||
| Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells | Q36398969 | ||
| The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein | Q36581891 | ||
| Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element | Q36797190 | ||
| Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. | Q36801839 | ||
| Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23 | Q36806063 | ||
| Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide | Q37358334 | ||
| B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. | Q37693393 | ||
| Epstein-Barr virus nuclear antigen 2-estrogen receptor fusion proteins transactivate viral and cellular genes and interact with RBP-J kappa in a conditional fashion. | Q38287860 | ||
| Expression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype | Q38289967 | ||
| Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes. | Q38302963 | ||
| EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. | Q38304806 | ||
| Activated mouse Notch1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters | Q39549769 | ||
| The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. | Q39551287 | ||
| Functional replacement of the intracellular region of the Notch1 receptor by Epstein-Barr virus nuclear antigen 2. | Q39582561 | ||
| Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21. | Q39882226 | ||
| Establishment in continuous culture of a new type of lymphocyte from a “burkitt-like” malignant lymphoma (line d.g.-75) | Q40039870 | ||
| Efficient somatic gene targeting in the lymphoid human cell line DG75. | Q40488177 | ||
| AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line | Q40714843 | ||
| Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless. | Q40793575 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 8784-8792 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | A somatic knockout of CBF1 in a human B-cell line reveals that induction of CD21 and CCR7 by EBNA-2 is strictly CBF1 dependent and that downregulation of immunoglobulin M is partially CBF1 independent | |
| P478 | volume | 79 |
| Q31032788 | A SILAC-based screen for Methyl-CpG binding proteins identifies RBP-J as a DNA methylation and sequence-specific binding protein |
| Q34733560 | Abortive lytic reactivation of KSHV in CBF1/CSL deficient human B cell lines |
| Q33657311 | Asymmetric Arginine dimethylation of Epstein-Barr virus nuclear antigen 2 promotes DNA targeting |
| Q31081505 | Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression |
| Q35101342 | Cellular target genes of Epstein-Barr virus nuclear antigen 2. |
| Q45382799 | Changes in chemokines and chemokine receptor expression on tonsillar B cells upon Epstein-Barr virus infection |
| Q37237334 | Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes |
| Q41926654 | EBF1 binds to EBNA2 and promotes the assembly of EBNA2 chromatin complexes in B cells. |
| Q38597233 | EBNA2 and Its Coactivator EBNA-LP. |
| Q35784734 | EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells |
| Q35889902 | EBNA3C Directs Recruitment of RBPJ (CBF1) to Chromatin during the Process of Gene Repression in EBV Infected B Cells |
| Q58746075 | Enhancer control of miR-155 expression in Epstein-Barr virus infected B cells |
| Q35024009 | Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway |
| Q34998257 | Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9 |
| Q38340693 | Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signaling. |
| Q34186964 | LEDGF/p75-independent HIV-1 replication demonstrates a role for HRP-2 and remains sensitive to inhibition by LEDGINs |
| Q34924659 | Loss of the Notch effector RBPJ promotes tumorigenesis |
| Q35049340 | Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages. |
| Q36769457 | Modulation of gene expression via overlapping binding sites exerted by ZNF143, Notch1 and THAP11 |
| Q51897964 | RBPJkappa-dependent signaling is essential for long-term maintenance of neural stem cells in the adult hippocampus. |
| Q38793717 | RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth. |
| Q37713998 | Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis. |
| Q36042686 | Synthetic Lethal Screen Demonstrates That a JAK2 Inhibitor Suppresses a BCL6-dependent IL10RA/JAK2/STAT3 Pathway in High Grade B-cell Lymphoma |
| Q35664999 | The EBNA-2 N-Terminal Transactivation Domain Folds into a Dimeric Structure Required for Target Gene Activation |
| Q38348963 | Wide-scale use of Notch signaling factor CSL/RBP-Jkappa in RTA-mediated activation of Kaposi's sarcoma-associated herpesvirus lytic genes |
Search more.